|
References
1. Lieberman
JA, Kane JM, Johns CA. Clozapine: Guidelines for Clinical Management.
J Clin Psychiatry 1989;50:9–13.
2. Gerson SL,
Meltzer H. Mechanisms of clozapine-induced agranulocytosis. Drug
Safety 1992;7 (Suppl.1):17–25.
3. Pisciotta
AV, Konings SA, Ciesemier LL, Cronkite CE, Lieberman JA. On the
possible mechanisms and predictability of clozapine-induced agranulocytosis.
Drug Safety 1992;7 (Suppl.1):33–44.
4. Veys PA,
Wilkes S, Shah S, Noyelle R, Hoffbrand AV. Clinical experience of
clozapine- induced neutropenia in the UK: laboratory investigation
using liquid culture systems and immuno-fenorocytometry. Drug Safety
1992;7 (Suppl. 1):26–32
5. Gerson SL,
Arce C, Meltzer HY. N-desmethyl clozapine: A clozapine metabolite
that suppresses Haemopoiesis. Br J Hematol 1994;86:555–61.
6. Centorrino
F, Baldessarini RJ, Flood JG, Kando JC, Frankenburg FR. Relation
of leucocyte counts during clozapine treatment to serum concentration
of clozapine and metabolites. Am J Psychiatry 1995;152:610–2.
7. Freeman DJ,
Li MC, Oyewumi LK. Solid-phase extraction and HPLC analysis of clozapine
and nor-clozapine in human plasma. Ther Drug Monit 1996;18:668–92.
8. Choc MG,
Lehr RG, Hsuan F, Honigfeld G, Smith HT. Multiple dose pharmacokinetics
of clozapine in patients. Pharmaceutic Res 1987;4:402–5.
9. Krupp P,
Barnes P. Clozapine-associated agranulocytosis: risk and aetiology.
Br J Psychiatry 1992;160 (Suppl 17):38–40.
10. Uetrecht
JP. Metabolism of clozapine by neutrophils. Possible implications
for clozapine-induced agranulocytosis. Drug Safety 1992;7 (Suppl
1):51–6.
--------------------------------------------------------------------------------
Manuscript received April 2001, revised,
and accepted February 2002.
1 Professor of Psychiatry, Queen’s University, Kingston, Ontario.
2 Professor of Psychiatry, University of Western Ontario, London,
Ontario.
3 Associate Professor, Faculty of Medicine, University of Western
Ontario, London, Ontario.
4 Director, Kunin-Lunefeld Applied Research Unit, Toronto, Ontario.
Address for correspondence: Dr LK Oyewumi, Hotel Dieu Hospital,
166 Brock St, Kingston, ON K7L 5G2
e-mail: oyewumik@post.queensu.ca
|
